{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:29:41Z","timestamp":1767860981338,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017094","name":"Department of Internal Medicine, University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.aace.2023.05.007","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T16:33:56Z","timestamp":1685637236000},"page":"158-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amelioration of Paget Disease of Bone After Denosumab for Osteopenia"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-7286","authenticated-orcid":false,"given":"Vijayvardhan","family":"Kamalumpundi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Shams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maisoon","family":"Torfah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3470-6234","authenticated-orcid":false,"given":"Marcelo L.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.aace.2023.05.007_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1759720X09351779","article-title":"Paget's disease of bone: a review of epidemiology, pathophysiology and management","volume":"1","author":"Shaker","year":"2009","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"10.1016\/j.aace.2023.05.007_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.beem.2018.05.005","article-title":"Paget's disease of bone","volume":"32","author":"Appelman-Dijkstra","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.aace.2023.05.007_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115465","article-title":"Bisphosphonates in the management of Paget's disease","volume":"138","author":"Ralston","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.aace.2023.05.007_bib4","series-title":"Bisphosphonate. StatPearls","author":"Ganesan","year":"2023"},{"issue":"5","key":"10.1016\/j.aace.2023.05.007_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jbmr.4235","article-title":"Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis","volume":"36","author":"Robinson","year":"2021","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.aace.2023.05.007_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SPC.0b013e328356062e","article-title":"Renal complications from bisphosphonate treatment","volume":"6","author":"Hirschberg","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"10.1016\/j.aace.2023.05.007_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00223-016-0150-6","article-title":"Treatment of Paget's disease of bone with denosumab: case report and literature review","volume":"99","author":"Reid","year":"2016","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"10.1016\/j.aace.2023.05.007_bib8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bone.2012.01.020","article-title":"Paget's disease of the bone after treatment with denosumab: a case report","volume":"50","author":"Schwarz","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.aace.2023.05.007_bib9","series-title":"Pathophysiology and treatment of Paget's disease of bone","author":"Kanis","year":"1998"},{"issue":"1-2","key":"10.1016\/j.aace.2023.05.007_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10354-016-0496-4","article-title":"Epidemiology and pathology of Paget's disease of bone - a review","volume":"167","author":"Nebot Valenzuela","year":"2017","journal-title":"Wien Med Wochenschr"},{"issue":"Suppl 2","key":"10.1016\/j.aace.2023.05.007_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650140218","article-title":"The neurologic complications of Paget's disease","volume":"14","author":"Poncelet","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"issue":"9","key":"10.1016\/j.aace.2023.05.007_bib12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","article-title":"Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease","volume":"353","author":"Reid","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.aace.2023.05.007_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.aace.2023.05.007_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bone.2004.03.023","article-title":"Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone","volume":"35","author":"Reid","year":"2004","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.aace.2023.05.007_bib15","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2013-1143","article-title":"Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease","volume":"98","author":"Grasemann","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.aace.2023.05.007_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1210\/jc.2013-3762","article-title":"Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency (\u201cBalkan\u201d mutation in the TNFRSF11B gene)","volume":"99","author":"Polyzos","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aace.2023.05.007_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1359\/jbmr.090709","article-title":"Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone","volume":"25","author":"Langston","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.aace.2023.05.007_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jbmr.3066","article-title":"Long-term randomized trial of intensive versus symptomatic management in Paget's disease of bone: the PRISM-EZ Study","volume":"32","author":"Tan","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.aace.2023.05.007_bib19","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1359\/jbmr.070704","article-title":"Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone","volume":"22","author":"Merlotti","year":"2007","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052300113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052300113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:32:31Z","timestamp":1762497151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S237606052300113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S237606052300113X"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2023.05.007","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amelioration of Paget Disease of Bone After Denosumab for Osteopenia","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2023.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}